| The Effect of FR167653, p38 Mitogen-Activated Protein Kinase (MAPK)
Inhibitor, on the Expression of Slit Diaphragm-Associated Proteins in
Experimental Diabetic Nephropathy |
| Dong-Ryeol Ryu, M.D.1, Tae-Hyun Yoo, M.D.2, Dong-Sub Jung, M.S.3, Seung-Jae Kwak, M.S.3.Je-Hyun Park, Ph.D.3, Sun-Ha Lee, M.S.3, Jin-ji Lee, M.D.3, Jung-Hwa Ryu, M.D.1, Mina Yu, M.D.1,Seung-Jung Kim, M.D.1, Duk-Hee Kang, M.D.1, Kyu Bok Choi, M.D.1, Kyun I |
Department of Internal Medicine1
School of Medicine, Ewha Womans University Department of Internal Medicine2
BK21 Project for Medical Science3 College of Medicine, Yonsei University, Seoul, Korea |
| 원저 : 당뇨 백서에서 p38 Mitogen-Activated Protein Kinase 억제제
(FR167653)가 세극막 관련 단백의 발현에 미치는 영향 |
| 류동열1․유태현2․정동섭3․곽승재3․박제현3․이순하3․이금희3․류정화1.유민아1․김승정1․강덕희1․최규복1․윤견일1․한대석2․강신욱2 |
| 이화여자대학교 의학전문대학원 내과학교실1, 연세대학교 의과대학 내과학교실2, BK21 의과학 사업단3 |
|
|
| Key Words:
Diabetic nephropathy, p38 mitogen-activated protein kinases, FR167653 |
|
PDF Links
Download Citation
